Symbotic Inc. (NASDAQ:SYM) Quarterly Earnings Preview
Financial Modeling Prep· 2026-02-03 14:00
Analysts predict a significant 366.7% increase in earnings per share to $0.08.Revenue is expected to rise by 27.9% to approximately $622.6 million.The company's stock has experienced a 101% surge over the past year, despite recent declines.Symbotic Inc. (NASDAQ:SYM) is gearing up to release its quarterly earnings on February 4, 2026. Analysts expect earnings per share to be $0.08, a significant 366.7% increase from the previous year. Revenue is projected to be around $622.6 million, reflecting a 27.9% rise ...
Camden CEO on why he’s seeing ‘huge’ investor demand for apartment buildings
CNBC· 2026-02-03 14:00
A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox.Fundamentals in the multifamily apartment market are weakening as a historic surge of new supply continues to make its way through the pipeline ...
KAYAK appoints Peer Bueller as Chief Executive Officer
Prnewswire· 2026-02-03 14:00
Co-Founder and Current CEO, Steve Hafner, named Executive Chair NORWALK, Conn., Feb. 3, 2026 /PRNewswire/ -- Booking Holdings, the world's leading provider of online travel and related services, and parent company of consumer-facing brands including Booking.com, Priceline, Agoda, KAYAK and OpenTable, announced that Peer Bueller has been named Chief Executive Officer of KAYAK. Peer Bueller joined KAYAK in 2016 as Chief Financial Officer and added Chief Operating Officer to his remit in 2021. Since joining K ...
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
Globenewswire· 2026-02-03 14:00
WILMINGTON, Del., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) cleared the Company to proceed with a Phase 1 study under its Investigational New Drug Application (IND) for PRT12396, a mutant-selective JAK2V617F inhibitor being developed for the treatment of patients with certain myeloproliferative neoplasms (MPNs). The Company anticipates dosing the first patient by Q2 of 202 ...
A Partner's Finances Can End a Relationship: 55% of Daters Surveyed Say Debt Can be a Dealbreaker, According to New Earnest Report
Prnewswire· 2026-02-03 14:00
This silence carries a heavy emotional toll: Despite these anxieties, the data suggests that debt is rarely a dealbreaker when met with a clear strategy: "In dating today, unmanaged debt is perceived as an unmanaged life. People aren't walking away because someone has debt; they're walking away because they don't see ownership," said Emily Childers, Chief Marketing Officer at Earnest. "A clear plan is the difference between a red flag and a green one." The full findings from Earnest's 2026 Debt and Dating R ...
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Navan, Inc. (NAVN)
TMX Newsfile· 2026-02-03 14:00
New York, New York--(Newsfile Corp. - February 3, 2026) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a shareholder and consumer rights litigation firm, is investigating whether Navan, Inc. ("Navan" or the "Company") (NASDAQ: NAVN) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTIONNavan is a cor ...
Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative
Prnewswire· 2026-02-03 14:00
QINGDAO, China, Feb. 3, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the launch of the an exploratory patient support program and a strategic cooperation with Nanning Duoling Research Institute. Adopting an integrated model of "Traditional Chinese Medicine (TCM) practice + modern medical technology", certain medical resources will be coordinated and integrated to provide free in-hospital treatment plans for up to 10,000 eligible patients within parti ...
Blackbaud Honored with Triple Award Recognition for Pioneering AI Innovation, Responsible Leadership, and Transformative Social Impact
Prnewswire· 2026-02-03 14:00
Leading AI company for social impact recognized by Business Intelligence Group, Responsible AI Institute, and Stevie Awards for transformative technology and ethical AI development Media Inquiries [email protected] CHARLESTON, S.C., Feb. 3, 2026 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the world's leading provider of AI-powered solutions for social impact, today announced it has received three prestigious industry awards recognizing the company's pioneering work in artificial intelligence, responsible tech ...
DuPont Launches Liveo™ C6-8XX Liquid Silicone Rubber Series for Healthcare Applications
Prnewswire· 2026-02-03 14:00
Improved-rheology medical-grade LSR offers process flexibility for fabricating medical devices, including devices intended for implantation in humans for less than 30 days, as well as for non-implant applications â"¢ WILMINGTON, Del., Feb. 3. 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of Liveo C6-8XX Liquid Silicone Rubber (LSR), a new USP Class VI (C6) series of medical-grade, two-part silicone elastomers engineered to meet the stringent requirements of medical device applications. â" ...
Cleantek Industries Provides 2026 Guidance
TMX Newsfile· 2026-02-03 14:00
Calgary, Alberta--(Newsfile Corp. - February 3, 2026) - Cleantek Industries Inc. (TSXV: CTEK) ("Cleantek" or the "Company"), a leading provider of patented clean technology solutions that reduce both cost and carbon intensity in the wastewater management and industrial lighting sectors, is proud to announce its financial and strategic outlook for Fiscal 2026. Building on recent momentum, including the significant international HALO SE Crown Mount contract awarded in January 2026, the Company remains focuse ...